The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Theravance Inc

Nasdaq: THRX
Last

(U.S.) $14.30

Today's change+0.39 +2.80%
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Theravance Inc

Nasdaq: THRX
Last

(U.S.) $14.30

Today's change+0.39 +2.80%
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.

Theravance Inc crosses above 20-day moving average

Theravance Inc closed up sharply Tuesday, rallying (U.S.)$0.39 or 2.80% to (U.S.)$14.30 and crossing above its 20-day moving average. Over the last five days, shares have gained 9.83%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 34.84% during the last year.

Key company metrics

  • Open(U.S.) $13.56
  • Previous close(U.S.) $13.91
  • High(U.S.) $14.39
  • Low(U.S.) $13.46
  • Bid / Ask-- / --
  • YTD % change+1.06%
  • Volume2,105,641
  • Average volume (10-day)555,121
  • Average volume (1-month)524,525
  • Average volume (3-month)546,361
  • 52-week range(U.S.) $10.58 to (U.S.) $23.84
  • Beta2.00
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.00
  • Dividend yield6.99%
  • Trailing EPS(U.S.) -$0.49
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX2.72%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue11771
Total other revenue--------
Total revenue11771
Gross profit--------
Total cost of revenue--------
Total operating expense66711
Selling / general / administrative5569
Research & development1112
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income510-10
Interest income (expense), net non-operating-13-13-13-12
Gain (loss) on sale of assets--------
Other--------
Income before tax-8-11-16-22
Income after tax-8-11-16-21
Income tax, total0----0
Net income-8-11-16-21
Total adjustments to net income--------
Net income before extra. items-8-11-16-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8-11-16-21
Inc. avail. to common incl. extra. items-8-11-16-21
Diluted net income-8-11-16-21
Dilution adjustment0000
Diluted weighted average shares115115114113
Diluted EPS excluding extraordinary itemsvalue per share-0.07-0.09-0.14-0.19
Dividends per sharevalue per share0.250.250.250.25
Diluted normalized EPSvalue per share-0.07-0.09-0.14-0.19